台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效

易威

(1799)
  • 股價
    65.0
  • 漲跌
    ▼2.3
  • 漲幅
    -3.42%
  • 成交量
    434
  • 產業
    上櫃 生技醫療類股▼0.26%
  • 73人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2025/04/16 ~ 2025/04/23     後一日»

券商獲利排行 - 2025/04/16 ~ 2025/04/23

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  11.12%266.10.4265.74041158.458.458.865
  11.00%257.70257.74040058.658.6065
  10.16%236.5-0.9237.43540558.258.25865
  11.84%11701171717058.158.1065
  10.44%104.50104.51717058.958.9065
  9.66%96.2492.21417358.658.459.765
  12.14%91.5091.512130585858.965
  11.21%78.6078.61212058.558.5065
  13.14%75.5075.51010057.557.5065
  9.23%70.9-0.1711213159.159.15965
  13.77%70.8070.899057.157.1065
  12.87%66.7066.799057.657.6065
  7.59%66.21452.2715858.257.559.365
  16.49%64.4064.477055.855.8065
  9.80%580581010059.259.2065
  9.34%55.5055.51010059.559.5065
  9.10%53.52.451.1810258.858.659.865
  9.36%49.4-0.750.189158.758.75865
  13.84%47.4047.466057.157.1065
  16.70%46.5046.555055.755.7065
  16.04%44.9044.95505656065
  15.04%42.5042.555056.556.5065
  10.10%40.9-1.14267157.95856.965
  10.61%37.4037.466058.858.8065
  2.33%37-10.547.58271958.859.158.565
  11.76%34.2034.255058.258.2065
  11.34%33.1033.155058.458.4065
  10.88%31.9031.955058.658.6065
  3.23%31.8-3.1355171257.95857.865
  10.85%31.8031.855058.658.6065
  8.84%30.9-1.632.556158.358.556.965
  10.24%30.2030.25505959065
  10.17%300305505959065
  12.80%29.5029.544057.657.6065
  12.12%28.1028.14405858065
  11.83%27.5027.544058.158.1065
  9.24%27.5027.555059.559.5065
  9.04%26.40.126.345158.458.458.565
  9.00%26.13.622.53525857.559.365
  15.04%25.5025.533056.556.5065
  7.29%21.4-1.823.235158.859.257.465
  12.13%21.1021.13305858065
  12.13%21.1021.13305858065
  11.94%20.8020.833058.158.1065
  11.36%19.9019.933058.458.4065
  16.49%18.4018.422055.855.8065
  10.36%18.3018.333058.958.9065
  16.18%18.1018.12205656065
  15.86%17.8017.822056.156.1065
  9.61%17.1017.133059.359.3065

券商虧損排行 - 2025/04/16 ~ 2025/04/23

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -11.15%-391.30-391.3-6006058.5058.565
  -10.84%-379.71.4-381.1-5726058.457.758.465
  -17.47%-338.40-338.4-3503555.3055.365
  -7.30%-265.7-13.1-252.6-39236258.759.158.565
  -9.31%-1639.1-172.1-2733058.455.658.665
  -4.65%-125.519.1-144.6-24224658.758.15965
  -5.63%-116.3-6.5-109.8-1817355959.358.965
  -15.63%-114.20-114.2-1301356.2056.265
  -9.22%-96.2-7.7-88.5-126185858.957.665
  -9.42%-66.32-68.3-1111258.656.858.865
  -9.17%-65.50-65.5-1201259.5059.565
  -10.14%-64.5-4.5-60-831157.85957.565
  -10.17%-600-60-100105905965
  -11.05%-57.30.8-58.2-81957.656.957.765
  -12.44%-56.9-6.3-50.6-62857.259.756.665
  -8.46%-54.1-4.3-49.8-641158.25957.965
  -5.42%-53.5-22.7-30.8-4131758.159.157.365
  -10.87%-510-51-80858.6058.665
  -13.74%-460-46-51655.855.855.865
  -15.86%-44.50-44.5-50556.1056.165
  -6.79%-40.63.5-44.1-911059.856.660.165
  -8.35%-39.60.2-39.8-71859.359.159.365
  -9.14%-38.10-38.1-70759.6059.665
  -2.75%-35.60.8-36.4-6162258.958.958.965
  -9.89%-35.10-35.1-60659.2059.265
  -8.03%-33.80-33.8-60760.258.660.265
  -10.17%-300-30-5055905965
  -10.17%-300-30-4055959.15965
  -12.37%-28.70-28.7-3045858.857.865
  -7.97%-27.4-10-17.4-24657.358.856.365
  -9.64%-270-27-32556565665
  -13.37%-230-23-30357.3057.365
  -2.22%-22.12.9-25-4131758.758.558.865
  -4.58%-21.5-7.6-13.9-26858.659.458.165
  -12.33%-21.40-21.4-30357.9057.965
  -0.61%-20.9-6-14.9-2575957.657.757.665
  -11.84%-20.60-20.6-30358.1058.165
  -11.11%-19.50-19.5-30358.5058.565
  -10.54%-18.60-18.6-30358.8058.865
  -10.43%-18.40-18.4-20358.85658.965
  -10.42%-18.40-18.4-30358.9058.965
  -10.18%-180-18-20358.956.65965
  -10.17%-180-18-3035905965
  -15.45%-17.40-17.4-20256.3056.365
  -9.69%-17.20-17.2-30359.356.659.365
  -9.67%-17.20-17.2-30359.3059.365
  -3.80%-15.62.4-18-24758.858.45965
  -12.07%-140-14-2025805865
  -7.59%-13.5-1.4-12.1-21359.360.358.965
  -3.57%-12.6-0.1-12.5-24658.858.858.865
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音